Letrozole used as API / frank@chembj.com

• Product NameLetrozole used as API / frank@chembj.com
  CAS No.112809-51-5
  Purity
  Min Quantity1000Kilograms
  Price2500~3900
• View Contact Detail

• 
  Molecular Structure

Detailed Description

Letrozole

CAS : 112809-51-5
Molecular Formula: C17H11N5
Apperance:White or light yellow crystal
Molecular Weight: 285.31
Usage: Used as API in Treatment of breast disease.
Detail:

Letrozole is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women.

Letrozole is intended for use only by women who are no longer of childbearing age. Possible candidates must have already ceased to menstruate. It is often used in patients who have already undergone other cancer treatments, such as radiation, chemotherapy, and used other cancer drugs, like tamoxifen. This nonsteroidal aromatase inhibitor may help prevent any remaining cancer cells from spreading.

Femara is used for the treatment of post-menopause breast cancer.
Femara is a powerful Aromatase Inhibitor that was developed to fight breast cancer. For athletes and bodybuilders, it is a drug used to combat the estrogenic side effects of anabolic steroids water-retention, acne and gynocomastia. It will also raise testosterone levels because of the lowered estrogen in the body. Side effects from include a lowered sex drive and continuous use can lead to lowered lipid function and an impaired immune system.
• 
• Letrozole used as API / frank@chembj.com